Search
for

    GlossarySubcision

    Subcision is a minimally invasive surgical procedure used to treat various skin conditions, including hair loss, by breaking up fibrous tissue that may be contributing to scarring or tethering of the skin. In the context of hair loss, subcision can help improve blood flow and promote the release of growth factors in the scalp, potentially enhancing hair follicle health and stimulating hair regrowth. Key distinguishing characteristics of subcision include its focus on the underlying connective tissue rather than the surface skin, and its ability to create a more favorable environment for hair follicles to thrive.

    Related Terms

    Sort by

    Community Join

    30 / 1000+ results

      community Breezula 6 Month Topline Phase III Results Released

      in Research/Science  173 upvotes 6 months ago
      Breezula shows promising hair growth results, with up to 539% increase in hair count compared to placebo, and regulatory submissions are planned in the US and EU. Users are cautiously optimistic, noting the potential for Breezula to replace finasteride by targeting DHT without systemic effects.

      community Clascoterone phase 3 results are out!

      in Treatment  83 upvotes 6 months ago
      Clascoterone phase 3 results show promising improvements in hair count, but concerns about high costs and lack of detailed data remain. Users compare it to existing treatments like Minoxidil and Finasteride, expressing skepticism about its accessibility and effectiveness.

      community What do we currently know about clascoterone?

      in Chat  5 upvotes 5 months ago
      Clascoterone is seen as a promising topical treatment for hair loss, similar to finasteride but without side effects, though concerns exist about its long-term effectiveness. Other treatments discussed include topical minoxidil, ketoconazole, microneedling, and oral options like dutasteride and minoxidil.

      community Why us no one talking about this?

      in Treatment  61 upvotes 6 months ago
      A new hair loss treatment reportedly shows a 539% improvement in hair count, but skepticism remains due to unclear placebo results and potential minimal actual hair growth. Many users doubt its effectiveness and market viability, citing high costs and lack of visual proof.

      community Does DHT Cause Complete Baldness?

      in Research/Science  5 upvotes 9 months ago
      Hair cloning technology is advancing, with clinical trials for improved methods expected by 2028 and 2029, potentially offering a solution for hair loss if donor follicles remain. Organtech's expansion into other biotech areas may secure funding, but the effectiveness of cloning depends on the availability of androgen-resistant donor follicles.

      community End of Year 1 [Fin/Min] SonsUK

      in Progress Pictures  503 upvotes 1 year ago
      The user shared impressive hair regrowth results after one year using oral finasteride and minoxidil spray, despite skepticism from some about the authenticity of the progress. The user experienced minimal side effects, such as an itchy scalp, and emphasized the importance of consistent use for maintaining results.

      community Clascoterone (Winlevi) Update for Canada

      in Treatment  15 upvotes 3 years ago
      Clascoterone cream was submitted for review to Health Canada in August 2022, with hopes of approval within 3-6 months. It may potentially enhance finasteride's effects for hair loss treatment.

      community Most promising cures for baldness as of May 2026

      in Treatment  56 upvotes 3 weeks ago
      PP405 is the most promising future treatment for hair loss, aiming to reactivate dormant hair follicles. Clascoterone 5% is the most promising near-term drug, while current strategies include using finasteride or dutasteride to stabilize hair loss and minoxidil to stimulate growth.

      community KX-826 Phase 3 Results Are Out

      in Research/Science  113 upvotes 2 months ago
      KX-826 shows promising results for hair growth with fewer side effects, offering an alternative to finasteride and minoxidil. Users discuss combining it with minoxidil, dermarolling, and Nizoral for improved results.

      community Clascoterone - what we have right now

      in Research/Science  23 upvotes 3 months ago
      Clascoterone is a topical treatment for androgenetic alopecia, showing modest to moderate hair regrowth, and may be available by 2027-2028. It is considered safer than finasteride, with discussions on its effectiveness compared to RU58841 and pyrilutamide.

      community Why doesn't phase 3 of PP405 start straight away?

      in Chat  14 upvotes 5 months ago
      Pelage is delaying the start of phase 3 trials for PP405 to 2026 due to necessary regulatory processes, despite having $120 million in funding. Users discuss the potential of PP405 for hair regrowth, with some expressing skepticism and others hopeful for new treatments like Breezula.

      community What’s your views on clascoterone 5% topical solution by cosmo

      in Research/Science  24 upvotes 6 months ago
      Clascoterone 5% topical solution shows promise for treating male-pattern hair loss by blocking DHT at the follicle without systemic absorption, potentially offering fewer side effects than oral treatments like finasteride. While results are promising, long-term safety and effectiveness need further study, and it may serve as a starting point for developing more effective treatments.

      community Apostles Creed: On The Third Day, He Rose Again From The Dead. 9 Months Dutasteride 1mg daily and Oral Minoxidil 2.5-5mg daily on Diffuse Unpatterned Alopecia

      in Progress Pictures  664 upvotes 2 years ago
      The conversation is about a person's positive experience with Dutasteride 1mg and Oral Minoxidil 2.5-5mg daily for Diffuse Unpatterned Alopecia, showing significant hair regrowth after 9 months. They mention a tough initial shedding phase, no side effects after 9 months, and a preference for oral treatments due to convenience and pet safety.

      community What ever happened to hairlosshelp.com ??!

      in Update  35 upvotes 3 years ago
      User began losing hair in 2006, used Avodart and got a hair transplant in 2012. They discuss the decline of hair loss forums and the shift to Reddit, which isn't ideal for long-form discussions.

      community Pre Fin Bloodwork To Check Other Potential Issues

      in Chat  21 upvotes 4 years ago
      A user preparing to start finasteride for hair loss wanted to check for any abnormal bloodwork related to hair loss. They shared their blood test results and learned from another user that their doctor prescribed finasteride without any preliminary tests.

      community Clascoterone 12 months phase 3 result out

      in Treatment  45 upvotes 2 months ago
      Clascoterone is promising for hair loss, showing 24.5% improvement in satisfaction compared to placebo. Users consider it an alternative to finasteride, with concerns about absorption and side effects.

      community My as soon as my son turns 18:

      in Satire  1982 upvotes 3 months ago
      Hair loss treatments like finasteride, dutasteride, and minoxidil are discussed, with differing views on when to begin treatment. Some suggest early use, while others warn of hormonal side effects from starting too young.

      community Has anyone seen the data on this 539% boost breakthrough?

      in Technology  867 upvotes 3 months ago
      Topical Clascoterone showed a 539% improvement in hair count compared to placebo, but its effectiveness and safety are debated. Users compared it to minoxidil and finasteride, with mixed opinions on its potential release in 2026 or 2027.

      community How long are Pelage going to milk the phase 2a results of PP405?

      in Chat  21 upvotes 4 months ago
      PP405, a potential hair loss treatment, is facing delays in releasing Phase 2 results, causing frustration among users who compare it to past failed treatments. Despite skepticism, some remain hopeful about PP405's future, while others discuss alternative treatments like Clascoterone and its expected market release.